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Background/aim: The reliability and validity of the Turkish version of the Leicester Cough Questionnaire (LCQ) have been evaluated
before. This study aimed to validate the Turkish version of the LCQ in chronic obstructive pulmonary disease (COPD) patients with
cough.
Materials and methods: COPD (GOLD B, C, D) patients over age 40 (n = 75) and healthy volunteers as a control group (n = 75) were
included. A sociodemographic data form, the LCQ, the Short Form-36 (SF-36) quality of life questionnaire, and the World Health
Organization Quality of Life Brief Form for Turkish people were completed. The internal reliability of the LCQ was determined using
the Cronbach alpha coefficient (>0.6) and its repeatability by the intraclass consistency coefficient (P < 0.05) was accepted as significant.
Results: For internal consistency, Cronbach alpha coefficients of all subscales of the LCQ, physical, psychological, and social, were found
as 0.72, 0.86, and 0.83, respectively, with 0.92 for the total index. There was significant internal consistency for all subscales and the total
index (Cronbach alpha coefficients of >0.6). In test–retest reliability, the correlation coefficient ranged between 0.71 and 0.80 for each
question and was calculated as r = 0.89 for total LCQ score (P < 0.001).
Conclusion: The Turkish version of the LCQ has been found to have acceptable reliability and validity for use in Turkish COPD patients
with chronic cough.
Key words: Chronic obstructive pulmonary disease, cough, quality of life, Leicester Cough Questionnaire

1. Introduction
Chronic cough, due to many etiologies, is defined as cough
that lasts longer than 8 weeks and has a significant effect
on the quality of life of the patient. Chronic obstructive
pulmonary disease (COPD) is clinically characterized by
progressive dyspnea, cough, and sputum expectoration.
It is important to demonstrate airway limitation in
diagnosing COPD, but it is also a cause of chronic cough
(1). The prevalence of chronic productive cough in COPD
is 15%–44% in males and 6%–17% in females. It is strongly
associated with smoking and older age (2). Chronic
productive cough in COPD may also be associated with
severe exacerbations requiring hospitalization, affecting
quality of life and general health status (3,4).
The Leicester Cough Questionnaire (LCQ) is a quality
of life questionnaire on chronic cough developed in the
UK. The questionnaire is short and easy to use and its
validity assessment is good. The Turkish reliability and
validity of this questionnaire were recently established (5).

The LCQ has been shown to be reproducible and a solution
provider in patients with chronic and acute cough (6).
Although cough is a frequent symptom, its impact on
health status in COPD patients is not known. There is not
any validated, cough-specific health status measurement
for COPD patients (7). There is also no Turkish
questionnaire that evaluates chronic cough in COPD
patients. We aimed to validate the Turkish version of the
LCQ in COPD patients with cough.
2. Materials and methods
This research is a cultural adaptation study of the
methodological (validity and reliability) type.
Approval of the Manisa Celal Bayar University Ethics
Committee was obtained (20478486-274/24.06.2015).
Seventy-five Turkish COPD Patients (GOLD B, C, D)
admitted to the Chest Diseases Clinic of Manisa Celal
Bayar University Hospital, who were over 40 year of age
and able to respond to the questions thoroughly, were
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included in the study (8). Seventy-five healthy volunteers
over 40 years old with no chronic disease were included as
a control group. Surveys were completed at baseline and 2
weeks later by the patient group.
The data collection package of the study was divided
into 4 parts, as described below.
2.1. Sociodemographic data form
Sex, age, educational status, comorbidity, and smoking
history were recorded.
2.2. Leicester Cough Questionnaire (LCQ)
The LCQ is a quality of life questionnaire associated
with chronic cough developed in the UK. It includes 19
subjects and 3 fields (physical, psychological, and social).
Subjects for the LCQ were selected by the clinical impact
factor method. This method selects topics that the patients
identify as problems and places them according to the
importance assigned to them. The topics are divided
into areas using clinical logic (9). The person fills out the
questionnaire according to a seven-unit Likert response
scale. High scores indicate better health status. The total
score is the sum of the 3 domains (physical, psychological
and social). The Turkish reliability and validity of the LCQ
in patients with chronic cough were established by Akis
Gonen et al. (5).
2.3. Short Form-36 (SF-36) Quality of Life Questionnaire
The SF-36 was developed by the Rand Corporation
in 1992. It includes questions about physical function
(10 questions), social function (2 questions), physical
role difficulty (4 questions), role of mental condition (3
questions), mental health (5 questions), energy/vitality (4
questions), pain (2 questions), general perception of health
(5 questions), and perception of change in health over the
last 12 months (1 question). It can evaluate the positive
aspects of the health situation as well as negative aspects.
The score obtained in this scale, consisting of 36 questions
with 8 subtitles, is between 0 and 100 and a special score
is obtained for each subtitle. When the score is higher, it
means that the health condition is better. The SF-36 is a
sensitive questionnaire for assessing changes in the quality
of life in COPD patients (10). A Turkish validity study was
conducted by Koçyiğit et al. (11).
2.4. Short Form of the World Health Organization Quality of Life Questionnaire for Turkish People (WHOQOLBREF-TR)
The WHOQOL-BREF has a total of 26 questions, including
two questions about ‘general perceived quality of life’ and
‘perceived health status’. The WHOQOL-BREF-TR was
modified by adding a question during Turkish validity
studies, so it consists of 27 questions including 5 areas that
are physical, mental, social, environmental, and national
environment with 0–20 points. The score increases as
quality of life improves. Turkish validity and reliability
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studies for WHOQOL-BREF-TR were performed by Eser
et al. (12).
2.5. Statistical method
Internal structure consistency (Cronbach alpha coefficient
of >0.6 being significant) and test–retest reliability (P <
0.05 being statistically significant) have been measured for
reliability analyses of the scale used in this study. Internal
structure consistency examines how scale items interact
in relation to each other and shows that scale items
measure approximately the same thing. In other words,
it investigates whether the questions in the scale form a
whole to explain a homogeneous construction. It can be
between 0 and 1. The range in which the alpha coefficient
can be found and therefore the confidence level of the scale
is as follows: 0.00 ≤ α <0.40 means the scale is not reliable,
0.40 ≤ α < 0.60 means the scale has low reliability, 0.60 ≤
α < 0. 80 means the scale is reliable, and 0.80 ≤ α < 1.00
means highly reliable.
For this purpose, the Cronbach alpha coefficient and
item-total score correlations have been calculated for each
item in the scale and for all subscales separately. For the
test–retest reliability, the test was performed twice in the
patient group at baseline and again 2 weeks later, to assess
the stability of the scale.
‘Validity together’ has been investigated for validity. For
this purpose, comparison of the SF-36 and WHOQOLBREF-TR, which were previously validated in Turkish,
was used. The relationship between the LCQ and the SF36 and WHOQOL-BREF-TR was calculated by Pearson
correlation coefficient. P < 0.05 was considered statistically
significant.
Chi-square, ANOVA, and Student t-tests were used to
compare sociodemographic and clinical features with LCQ
scores. P < 0.05 was considered statistically significant.
For the statistical analyses, SPSS 15.0 for Windows 15.0
was used.
3. Results
Most of the 75 patients were male (94.6%) and the mean
age was 62.32 ± 7.8 years. The sociodemographic findings
of the 75 patients and the 75 control subjects are shown in
Table 1.
A significant difference in sex and age was found (P <
0.05) among the sociodemographic characteristics of the
groups. However, a limitation of the study was that most
of the patients with cough were male while in the control
group most subjects were female. A similar pattern was
observed for the smoking status and educational status of
the patients (P < 0.05).
3.1. Results of reliability of the questionnaire
3.1.1. Internal consistency
The Cronbach alpha coefficient for each subscale and for
all tests was calculated. It was observed that all subgroups
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Table 1. Social demographic characteristics of patients and control group.

Age, years, mean ± SD
Sex,
n, (%)
Educational level,
n, (%)
Comorbidities,
n, (%)
Smoking status,
n, (%)

COPD group
(n = 75)

Control group
(n = 75)

P

62.32 ± 7.8

55.45 ± 8.0

<0.05
<0.05

Female

4 (5.4%)

37 (49.3%)

Male

71 (94.6%)

38 (50.7%)

Literate

17 (22.6%)

11 (14.6%)

Primary education

52 (69.3%)

25 (33.3%)

High school

5 (6.6%)

16 (21.3%)

University

1 (1.3%)

23 (30.6%)

Yes

31 (41.3%)

26 (34.6%)

No

44 (58.7%)

49 (65.4%)

Nonsmoker

1 (1.3%)

40 (53.3%)

Exsmoker

54 ( 72.0%)

19 (25.5%)

Current smoker

20 (26.7%)

16 (21.3%)

had significant internal consistency. For the physical,
psychological, and social subgroups of the LCQ, the
Cronbach alpha coefficient was 0.72, 0.86, and 0.83,
respectively (Table 2).
Item-total correlation coefficients between 0.55 and
0.67 were obtained for the whole scale evaluation and
the Cronbach alpha coefficient was 0.89 (Table 2). The
medium and high level item-total correlation coefficients
for all items were determined.
In the internal consistency evaluation, the Cronbach
alpha coefficient for the subgroups and the whole scale was
>0.6, supporting the test’s reliability.
3.1.2. Test–retest method
The relationship between the scores of the patients as
a result of test–retest was statistically evaluated by the
Pearson correlation test. In the test–retest reliability, the
correlation coefficient of the subgroups of the LCQ ranged
from 0.71 to 0.80 (P < 0.001). At the same time, there
was a high correlation for total LCQ score in test–retest
reliability (r = 0.89, P < 0.001) (Table 3).
The test–retest reliability was examined for each
question and the correlation coefficient was found to be
between 0.61 and 0.78 (P < 0.001).
There was no statistically significant difference between
LCQ total and subscale scores in the first and second
evaluation of the patient group (P > 0.05) (Table 3).
When the relationship between the LCQ subscales
and the SF-36 subscales was examined, the correlation
values (including

each subscale) supported a significant
relationship between the two tests (P < 0.05). The highest
correlation was found between the physical, psychological,
and social subscales and total scores of the LCQ and SF-

<0.05

0.251

<0.05

36 general health subscale (respectively r = 0.62, 0.54,
0.57, 0.6), whereas the lowest correlation for the physical
subscale of LCQ (r = 0.25) was with the emotional role
difficulties of the SF-36, and for other subscales and the
total score of LCQ it was with the SF-36 physical function
subscale (respectively r = 0.21, 0.23, 0.57).
Correlation between the LCQ subscales and the
WHOQOL-BREF-TR subscales also supported the
compatibility of the two tests (P < 0.05). The lowest
correlation between the physical subscale and total
score of LCQ was with the WHOQOL-BREF-TR social
relationships (respectively r = 0.36, 0.41) and the highest
correlation was with the physical area (r = 0.49).
4. Discussion
Our study evaluating the validity and reliability of the
Turkish version of the LCQ in COPD patients has shown
that the Turkish version of the LCQ provides reliable
measurement in COPD patients as well as in the general
population.
Chronic cough is an important symptom that affects
the quality of life of patients and has physical, social,
and psychosocial effects. Studies have been performed
to evaluate the impact of it on quality of life in different
patient groups (13–17). Although cough is one of the three
most common complaints of COPD patients, it is usually
treated as a natural symptom by the effect of smoking
in this group of patients. There is also no study done
regarding cough symptom in COPD. This could be likely
due to the lack of valid assessment tools.
When we compared the patient and control groups
in our study, male sex, older age, and smoking were
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Table 2. Item-total statistics for the LCQ subscales and total index.
Corrected item-total correlation (r),
subscales / total index

Alpha value when this item is not
available, subscales / total index

LCQ1 (Physical)

0.59 / 0.61

0.69 / 0.87

LCQ2 (Physical)

0.58 / 0.61

0.70 / 0.86

LCQ3 (Physical)

0.58 / 0.60

0.67 / 0.86

LCQ4 (Psychological)

0.65 / 0.60

0.72 / 0.87

LCQ5 (Psychological)

0.65 / 0.58

0.75 / 0.89

LCQ6 (Psychological)

0.68 / 0.63

0.77 / 0.90

LCQ7 (Social)

0.61 / 0.68

0.73 / 0.84

LCQ8 (Social)

0.66 / 0.58

0.76 / 0.86

LCQ9 (Physical)

0.52 / 0.65

0.67 / 0.86

LCQ10 (Physical)

0.50 / 0.56

0.69 / 0.84

LCQ11 (Physical )

0.53 / 0.64

0.67 / 0.90

LCQ12 (Psychological)

0.69 / 0.61

0.80 / 0.88

LCQ13 (Psychological)

0.69 / 0.57

0.74 / 0.91

LCQ14 (Physical)

0.52 / 0.57

0.69 / 0.84

LCQ15 (Physical)

0.58 / 0.64

0.69 / 0.90

LCQ16 (Psychological)

0.66 / 0.65

0.72 / 0.87

LCQ17 (Psychological)

0.74 / 0.63

0.81 / 0.94

LCQ18 (Social)

0.69 / 0.62

0.77 / 0.92

LCQ19 (Social)

0.70 / 0.65

0.78 / 0.88

Physical subgroup: alpha: 0.72.
Psychological subgroup: alpha: 0.86.
Social subgroup: alpha: 0.83.
Total: alpha: 0.89.
Table 3. Test–retest reliability of the Leicester Cough Questionnaire.
First assessment

Second assessment

r/P

Physical, mean ± SD

4.80 ± 1.25

4.75 ± 1.29

0.71 / 0.58

Psychological, mean ± SD

4.73 ± 1.44

4.67 ± 1.37

0.80 / 0.51

Social, mean ± SD

4.29 ± 1.68

4.25 ± 1.72

0.79 / 0.58

Total, mean ± SD

13.82 ± 4.36

13.67 ± 4.39

0.89 / 0.42

significantly different in patients with chronic cough (P
< 0.05). Mello et al. found the rate of women to be 72%
in patients with chronic cough complaints (14). This is
usually explained by increased cough reflex sensitivity in
women. It has been reported that although men reported
more severe cough complaints, women had more coughrelated applications and cough further deteriorated the
quality of life in women (15–17). Kelsall et al. found no
difference between women and men in LCQ scores (18).
In our study, we found cough to be more common in men.
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However, this result may be influenced by the fact that
most of the patients were male and the control group was
mostly female.
The effect of tobacco on cough is known. In a casecontrol study of 2000 people performed by Jansen et al.,
there was an increased prevalence of chronic cough among
smokers (19). In our study, smoking history, which is the
most important risk factor of COPD, was more frequent
in the group of patients with chronic cough than in the
control group (98% and 46%, respectively). There were
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patients in both groups who continued to smoke actively
(n = 20 and 16, respectively). Smoking was more frequent
in the patient group, which may be another limiting factor
in our study.
Internal consistency has been determined for each
subscale (physical, psychological, social) and for the whole
test in our study in which we tested the Turkish validity
and reliability of the LCQ for COPD patients (respectively
Cronbach alpha coefficients of 0.72, 0.86, 0.83, and 0.89). The
weakest internal consistency was in the physical subgroup.
Three items (questions 9, 10, and 14) related to hoarseness,
odor sensitivity, and sleep influence were the questions
that provided the greatest contribution to this low value.
In a validation-accuracy study of patients with COPD
from the Netherlands, the lowest Cronbach alpha
coefficient was also obtained with regard to energy loss
with hoarseness and odor sensitivity (7). Considering
that most COPD patients are smoking, and most of them
complain about hoarseness and weakness, these questions
may be considered as weaker indicators of chronic cough
in COPD patients.
Our study showed that there was test–retest reliability
of the Turkish version of the LCQ for each subscale and
the whole scale in COPD patients.
In the validity and reliability study of the LCQ Dutch
version, it was seen that the LCQ was a highly reproducible
and change-sensitive questionnaire. It was stated that this
questionnaire could be used to assess and evaluate the
clinical outcomes associated with coughing (20). In a
study conducted by Berkhoff et al. in COPD patients, it
was also found that the LCQ was reproducible and that
the correlation coefficient scores of test–retest reliability
for the subscales and total scale were above 0.70, similar to
our study (7). These data support the claim that the LCQ is
reproducible in COPD patients with chronic cough.
When we examined the relationship between LCQ
subscales and SF-36 subscales in our study, it was seen that
there was a significant correlation in all subunits, similar
to the literature (<0.05). This supports the results of the
study by Kalpaklıoğlu et al. in patients with postnasal
drip, asthma, and gastroesophageal reflux, which were
the most common causes of chronic cough (21). In the
Turkish validity study of the LCQ in patients with chronic
cough, the relationship between LCQ subscales and SF-36
subscales was found to be significant, in parallel with our
study (5). Kwon et al. also found it compatible with the SF36 in a validity and reliability study with 202 patients with
chronic cough (Cronbach alpha correlation coefficient:
0.42–0.58) (22).

French et al. assessed the LCQ as a shorter, usable
questionnaire in a validation study of patients with
COPD in France using the Cough-Specific Quality of Life
Questionnaire (23). Sönnerfors et al. also showed that
the questionnaire correlated with the Swedish version of
the LCQ with the St George’s Respiratory Questionnaire
and the COPD Assessment Test, and indicated that the
questionnaire could be used (24). Reychler et al. also
tested the French version of the questionnaire with the
Cough and Sputum Assessment Questionnaire and found
a strong correlation (25). The study of Birring et al. also
showed that the LCQ is suitable for use in many areas.
It is firstly useful in detecting changes in chronic cough
patients and secondly is influential in assessing healthrelated conditions affected by cough and showing how it
changes over time. Finally, it can be used in clinical trials
evaluating the efficacy of new treatments for cough and
quality of life (9).
In our study, there was also a correlation between LCQ
subscales and WHOQOL-BREF-TR subscales, and there
was a significant correlation between the two tests (P <
0.05). Akis Gonen et al. found a statistically significant
correlation between LCQ subscales and WHOQOLBREF-TR subscales in Turkish validity and reliability
studies in patients with chronic cough (5). This is in line
with our research results.
The most important limitation of our research was
that the patient group consisted mainly of males and the
control group consisted of mainly females. The fact that
smoking was more frequent in the patient group has
been considered another factor of limitation. It has been
thought that the main cause of these differences was the
COPD patients who constituted the study group. Another
limitation was the age difference between the study and
control group. The most important cause of this age
difference may that COPD patients are predominantly
in the older age group, and it was difficult to find healthy
individuals for the control group in this age group.
The LCQ is a short, easily applicable, and reproducible
questionnaire in COPD patients. It has also been validated
with health-related quality of life questionnaires. Our data
support that the Turkish version of the LCQ is a valid and
reliable questionnaire that can be used in patients with
chronic cough and asthma as well as COPD patients. Using
the Turkish version of this questionnaire in COPD patients
with chronic cough may contribute to the evaluation of
patients’ quality of life and the approach to coughing.
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